184 related articles for article (PubMed ID: 27495122)
1. Targeting bactoprenol-coupled cell envelope precursors.
Ulm H; Schneider T
Appl Microbiol Biotechnol; 2016 Sep; 100(18):7815-25. PubMed ID: 27495122
[TBL] [Abstract][Full Text] [Related]
2. Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
Schneider T; Sahl HG
Curr Opin Investig Drugs; 2010 Feb; 11(2):157-64. PubMed ID: 20112165
[TBL] [Abstract][Full Text] [Related]
3. Lipid II as a target for antibiotics.
Breukink E; de Kruijff B
Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
[TBL] [Abstract][Full Text] [Related]
4. New Found Hope for Antibiotic Discovery: Lipid II Inhibitors.
Ng V; Chan WC
Chemistry; 2016 Aug; 22(36):12606-16. PubMed ID: 27388768
[TBL] [Abstract][Full Text] [Related]
5. Targeting a cell wall biosynthesis hot spot.
Müller A; Klöckner A; Schneider T
Nat Prod Rep; 2017 Jul; 34(7):909-932. PubMed ID: 28675405
[TBL] [Abstract][Full Text] [Related]
6. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
Grein F; Schneider T; Sahl HG
J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
[TBL] [Abstract][Full Text] [Related]
7. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
8. The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate.
Schneider T; Gries K; Josten M; Wiedemann I; Pelzer S; Labischinski H; Sahl HG
Antimicrob Agents Chemother; 2009 Apr; 53(4):1610-8. PubMed ID: 19164139
[TBL] [Abstract][Full Text] [Related]
9. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
Schneider T; Sahl HG
Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776
[TBL] [Abstract][Full Text] [Related]
10. Expanding role of lipid II as a target for lantibiotics.
Martin NI; Breukink E
Future Microbiol; 2007 Oct; 2(5):513-25. PubMed ID: 17927474
[TBL] [Abstract][Full Text] [Related]
11. Total Synthesis of Laspartomycin C and Characterization of Its Antibacterial Mechanism of Action.
Kleijn LH; Oppedijk SF; 't Hart P; van Harten RM; Martin-Visscher LA; Kemmink J; Breukink E; Martin NI
J Med Chem; 2016 Apr; 59(7):3569-74. PubMed ID: 26967152
[TBL] [Abstract][Full Text] [Related]
12. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
Münch D; Sahl HG
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
[TBL] [Abstract][Full Text] [Related]
13. Targeting extracellular pyrophosphates underpins the high selectivity of nisin.
Bonev BB; Breukink E; Swiezewska E; De Kruijff B; Watts A
FASEB J; 2004 Dec; 18(15):1862-9. PubMed ID: 15576489
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
[TBL] [Abstract][Full Text] [Related]
15. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
Oppedijk SF; Martin NI; Breukink E
Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity exploration of a small-molecule Lipid II inhibitor.
Fletcher S; Yu W; Huang J; Kwasny SM; Chauhan J; Opperman TJ; MacKerell AD; de Leeuw E
Drug Des Devel Ther; 2015; 9():2383-94. PubMed ID: 25987836
[TBL] [Abstract][Full Text] [Related]
17. Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity.
Scherer K; Wiedemann I; Ciobanasu C; Sahl HG; Kubitscheck U
Biochim Biophys Acta; 2013 Nov; 1828(11):2628-36. PubMed ID: 23872123
[TBL] [Abstract][Full Text] [Related]
18. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
Stegmann E; Frasch HJ; Kilian R; Pozzi R
Int J Med Microbiol; 2015 Feb; 305(2):190-5. PubMed ID: 25601631
[TBL] [Abstract][Full Text] [Related]
19. Control of bacteria adhesion by cell-wall engineering.
Sadamoto R; Niikura K; Ueda T; Monde K; Fukuhara N; Nishimura S
J Am Chem Soc; 2004 Mar; 126(12):3755-61. PubMed ID: 15038728
[TBL] [Abstract][Full Text] [Related]
20. Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics.
de Kruijff B; van Dam V; Breukink E
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):117-21. PubMed ID: 19008088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
